-
1
-
-
33845396315
-
Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals
-
Busnach G, Piselli P, Arbustini E et al (2006) Immunosuppression and cancer: A comparison of risks in recipients of organ transplants and in HIV-positive individuals. Transplant Proc 38:3533-3535
-
(2006)
Transplant Proc
, vol.38
, pp. 3533-3535
-
-
Busnach, G.1
Piselli, P.2
Arbustini, E.3
-
2
-
-
0028296461
-
High incidence of anal cancer among AIDS patients
-
The AIDS/Cancer Working Group
-
Melbye M, Cote TR, Kessler L et al (1994) High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 343:636-639
-
(1994)
Lancet
, vol.343
, pp. 636-639
-
-
Melbye, M.1
Cote, T.R.2
Kessler, L.3
-
3
-
-
0022457195
-
Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases
-
Penn I (1986) Cancers of the anogenital region in renal transplant recipients. Analysis of 65 cases. Cancer 58:611-616
-
(1986)
Cancer
, vol.58
, pp. 611-616
-
-
Penn, I.1
-
4
-
-
0028012574
-
The risk of ano-genital malignancies in dialysis and transplant patients
-
Fairley CK, Sheil AG, McNeil JJ et al (1994) The risk of ano-genital malignancies in dialysis and transplant patients. Clin Nephrol 41:101-105
-
(1994)
Clin Nephrol
, vol.41
, pp. 101-105
-
-
Fairley, C.K.1
Sheil, A.G.2
McNeil, J.J.3
-
5
-
-
34247847993
-
Malignancies of the colorectum and anus in solid organ recipients
-
Aigner F, Boeckle E, Albright J et al (2007) Malignancies of the colorectum and anus in solid organ recipients. Transpl Int 20:497-504
-
(2007)
Transpl Int
, vol.20
, pp. 497-504
-
-
Aigner, F.1
Boeckle, E.2
Albright, J.3
-
6
-
-
0028146556
-
Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy
-
Holland JM, Swift PS (1994) Tolerance of patients with human immunodeficiency virus and anal carcinoma to treatment with combined chemotherapy and radiation therapy. Radiology 193:251-254
-
(1994)
Radiology
, vol.193
, pp. 251-254
-
-
Holland, J.M.1
Swift, P.S.2
-
7
-
-
0034795627
-
HIVpositive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients
-
Kim JH, Sarani B, Orkin BA et al (2001) HIVpositive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum 44:1496-1502
-
(2001)
Dis Colon Rectum
, vol.44
, pp. 1496-1502
-
-
Kim, J.H.1
Sarani, B.2
Orkin, B.A.3
-
8
-
-
0033009171
-
The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer
-
Hoffman R, Welton ML, Klencke B et al (1999) The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44:127-131
-
(1999)
Int J Radiat Oncol Biol Phys
, vol.44
, pp. 127-131
-
-
Hoffman, R.1
Welton, M.L.2
Klencke, B.3
-
9
-
-
84875202880
-
Acute radiation morbidity scoring criteria
-
Radiation Therapy Oncology Group
-
Radiation Therapy Oncology Group (2008) Acute Radiation Morbidity Scoring Criteria. RTOG. http://www.rtog.org/members/toxicity/acute.html
-
(2008)
RTOG
-
-
-
10
-
-
84875172302
-
European organization for research and treatment of cancer. RTOG/EORTC Late radiation morbidity scoring schema
-
Radiation Therapy Oncology Group
-
Radiation Therapy Oncology Group (2008) European Organization for Research and Treatment of Cancer. RTOG/EORTC Late radiation morbidity scoring schema. RTOG. http://www.rtog.org/members/toxicity/late.html
-
(2008)
RTOG.
-
-
-
11
-
-
21244472380
-
Anal carcinomas in HIV-positive patients: Highdose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy
-
Blazy A, Hennequin C, Gornet J-M et al (2005) Anal carcinomas in HIV-positive patients: Highdose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 48:1176-1181
-
(2005)
Dis Colon Rectum
, vol.48
, pp. 1176-1181
-
-
Blazy, A.1
Hennequin, C.2
Gornet, J.-M.3
-
12
-
-
0027998565
-
Squamous-cell carcinoma of the anus in HIV-positive patients
-
Chadha M, Rosenblatt EA, Malamud S et al (1994) Squamous-cell carcinoma of the anus in HIV-positive patients. Dis Colon Rectum 37:861-865
-
(1994)
Dis Colon Rectum
, vol.37
, pp. 861-865
-
-
Chadha, M.1
Rosenblatt, E.A.2
Malamud, S.3
-
13
-
-
0034114646
-
Treatment of HIV-associated invasive anal cancer with combined chemoradiation
-
Cleator S, Fife K, Nelson M et al (2000) Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 36:754-758
-
(2000)
Eur J Cancer
, vol.36
, pp. 754-758
-
-
Cleator, S.1
Fife, K.2
Nelson, M.3
-
14
-
-
33746813100
-
Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities
-
Edelman S, Johnstone PAS (2006) Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities. Int J Radiat Oncol Biol Phys 66:206-211
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.66
, pp. 206-211
-
-
Edelman, S.1
Johnstone, P.A.S.2
-
15
-
-
0030982363
-
Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal
-
Peddada AV, Smith DE, Rao AR et al (1997) Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 37:1101-1105
-
(1997)
Int J Radiat Oncol Biol Phys
, vol.37
, pp. 1101-1105
-
-
Peddada, A.V.1
Smith, D.E.2
Rao, A.R.3
-
16
-
-
42449128805
-
Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial
-
Ajani JA, Winter KA, Gunderson LL et al (2008) Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial. JAMA 299:1914-1921
-
(2008)
JAMA
, vol.299
, pp. 1914-1921
-
-
Ajani, J.A.1
Winter, K.A.2
Gunderson, L.L.3
-
17
-
-
0031004470
-
Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer
-
results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups
-
Bartelink H, Roelofsen F, Eschwege F et al (1997) Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15:2040-2049
-
(1997)
J Clin Oncol
, vol.15
, pp. 2040-2049
-
-
Bartelink, H.1
Roelofsen, F.2
Eschwege, F.3
|